Search

everythinglearnresearchcommunity

for

Search:↓

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Dermabrasion is a skin resurfacing technique with specific steps and potential complications.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

A vitamin D3 compound can reduce skin cell growth.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

Acitretin helped improve hand mobility and skin condition in a patient.

Topical glycopyrrolate lotion helped reduce excessive sweating from eating in a diabetic man.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

The Q-switched ruby laser effectively lightened eyebrow tattoos but may reduce eyebrow hair density.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

Deoxycholic acid effectively reduces double chin fat with temporary side effects and high patient satisfaction.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Targeting the AhR pathway may help treat alopecia areata.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Technique effectively treats deformities, achieves re-pigmentation, and releases scar contractures.

Adenosine helps grow thicker hair in Japanese men with hair loss.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

8-OHdG may help diagnose and assess alopecia areata.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.